# OnCo record elritercept (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/elritercept/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "elritercept" ;
  schema:name "Elritercept"@en ;
  schema:alternateName "TAK-226"@en ;
  schema:description "Elritercept is Keros and Takeda's ligand trap for the anaemia of myelodysplastic syndromes, a relative of luspatercept, in phase 3 trials."@en ;
  schema:url <https://onco.cc/drugs/elritercept/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=KER-050> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Activin receptor type IIA ligand trap (fusion protein), subcutaneous" ;
  onco:cancers <https://onco.cc/cancers/mds/> ;
  onco:technologies <https://onco.cc/technologies/cytokine-therapy/> ;
  onco:companies <https://onco.cc/companies/keros-therapeutics/>, <https://onco.cc/companies/takeda/> ;
  onco:trials <https://onco.cc/trials/nct06499285/> .